Myofibroblastic differentiation in atypical fibroxanthomas occurring on sun-exposed skin and in a burn scar: An ultrastructural and immunohistochemical study

Journal of Cutaneous Pathology

Volumn 38, Issue 8, 2011, Pages 670-676

  Ito, Ayako ^a   Yamada, Nanako ^a   Yoshida, Yuichi ^a   Morino, Shinichi ^b   Yamamoto, Osamu ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

atypical fibroxanthoma; burn scar; electron microscopy; immunohistochemistry; myofibroblast

Indexed keywords

MEMBRANE METALLOENDOPEPTIDASE; TUMOR MARKER; VIMENTIN;

AGED; ARTICLE; BURN; CASE REPORT; CELL NUCLEUS; CELL TRANSFORMATION; DERMATOFIBROMA; FEMALE; HUMAN; LYSOSOME; MALE; METABOLISM; MICROFILAMENT; MYOFIBROBLAST; PATHOLOGY; RADIATION EXPOSURE; SCAR; SKIN; SKIN TUMOR; SUNLIGHT; ULTRASTRUCTURE;

AGED, 80 AND OVER; BURNS; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CICATRIX; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; LYSOSOMES; MALE; MICROFILAMENTS; MYOFIBROBLASTS; NEPRILYSIN; SKIN; SKIN NEOPLASMS; SUNLIGHT; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 79960556814     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2011.01708.x     Document Type: Article

References (39)

1. Helwig EB., Atypical fibroxanthoma. Proceedings of 18 th annual tumor seminar of san antonio society of pathologists, 1961. Texas State J Med 1963; 59: 664.
2. Kempson RL, McGavran MH., Atypical fibroxanthomas of the skin. Cancer 1964; 17: 1463.
3. Fretzin DF, Helwig EB., Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases. Cancer 1973; 31: 1541.
4. Longacre TA, Smoller BR, Rouse RV., Atypical fibroxanthoma. Multiple immunohistologic profiles. Am J Surg Pathol 1993; 17: 1199.
5. Mirza B, Weedon D., Atypical fibroxanthoma: a cliicopathological study of 89 cases. Austral J Dermatol 2005; 46: 255.
6. Luzar B, Calonje E., Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review. J Cutan Pathol 2010; 37: 301.
7. Rudisaile SN, Hurt MA, Santa Cruz DJ., Granular cell atypical fibroxanthoma. J Cutan Pathol 2005; 32: 314.
8. Requena L, Sangueza OP, Sánchez Yus E, Furio V., Clear-cell atypical fibroxanthoma: an uncommon histopathologic variant of atypical fibroxanthoma. J Cutan Pathol 1997; 24: 176.
9. Orlandi A, Bianchi L, Ferlosio A, Innocenzi I, Spagnoli LG., The origin of osteoclast-like giant cells in atypical fibroxanthoma. Histopathology 2003; 42: 407.
10. Diaz-Cascajo C, Weyers W, Borghi S., Pigmented atypical fibroxanthoma. A tumor that may be easily mistaken for malignant melanoma. Am J Dermatopathol 2003; 25: 1.
11. Kim J, McNiff JM., Keloidal atypical fibroxanthoma. J Cutan Pathol 2009; 36: 535.
12. Nakayama R, Nemoto T, Takahashi H, et al., Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Mod Pathol. 2007; 20: 749.
13. Enzinger FM, Weiss SW., Soft tissue tumors, 3rd ed. St. Louis: Mosby, 1995.
14. Wick MR, Fitzgibbon J, Swanson PE., Cutaneous sarcomas and sarcomatoid neoplasms of the skin. Semin Diagn Pathol 1993; 10: 148.
15. Zelger B, Soyer HP., Between Scylla and Charybdis: mythology in dermatopathology. Dermatopathol Pract Concept 2000; 6: 348.
16. Sakamoto A, Oda Y, Yamamoto H, et al., Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma. Virchows Arch 2002; 440: 404.
17. Ghadially FN., Diagnostic electron microscopy of tumors, 2nd ed. London: Butterworths, 1985.
18. Eckert F, Schaich B, Landthaler M., Spinozelluläre Karzinome und myxoides atypisches Fibroxanthom auf aktinisch geschädigter Verbrennubgsnarbe. Hautarzt 1991; 42: 254.
19. Hiscutt EL, Adams JR, Ryan JM, Langtry JA, Natarajan S., Atypical fibroxanthoma, lentigo maligna melanoma and squamous cell carcinoma arising in the site of a thermal burn treated with skin grafts. Br J Oral Max Surg 2009; 47: 157.
20. Kaddu S., Cutaneous leiomyosarcoma. Am J Surg Pathol 1997; 21: 979.
21. Weedon D, Kerr JR., Atypical fibroxanthoma of skin: an electron microscopic study. Pathology 1975; 7: 173.
22. Starink TM, Hausman R, van Delden L, Neering H., Atypical fibroxanthoma of the skin. Presentation of 5 cases and a review of the literature. Br J Dermatol 1977; 97: 167.
23. Alguacil-Garcia A, Unni KK, Goellner JR, Winkelmann RK., Atypical fibroxanthoma of the skin. An ultrastructural study of two cases. Cancer 1977; 40: 1471.
24. Mandard AM, Herlin P, Chasle J, Romain C, Wyplosz J, Abbatucci JS., Cutaneous pseudosarcomas. Electron microscopic study of three tumors. J Submicr Cytol 1978; 10: 441.
25. Eyden B., The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. Part 1. Normal and reactive cells. J Submicrosc Cytol Pathol 2005; 37: 109.
26. Eyden B., The myofibroblast: an assessment of controversial issues and a definition useful in diagnosis and research. Ultrastruct Pathol 2001; 25: 39.
27. Eyden B., Electron microscopy in the study of myofibroblastic lesions. Semin Diagn Pathol 2003; 20: 13.
28. Eyden B., The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. Part 2. Tumours and tumour-like lesions. J Submicrosc Cytol Pathol 2005; 37: 231.
29. Eyden B., The fibronexus in reactive and tumoral myofibroblasts: further characterization by electron microscopy. Histol Histopathol 2001; 16: 57.
30. Hultgren TL, DiMaio DJ., Immunohistochemical staining of CD10 in atypical fibroxanthomas. J Cutan Pathol 2007; 34: 415.
31. Ma CK, Zarbo RJ, Gown AM., Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans. Am J Surg Pathol 1992; 97: 478.
32. Mentzel T, Dry S, Katenkamp D, et al., Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors. Am J Surg Pathol 1998; 22: 1228.
33. Clarke LE, Frauenhoffer E, Fox E, Neves R, Bruggeman RD, Helm KF., CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma. J Cutan Pathol 2010; 37: 737.
34. Jensen K, Wilkinson B, Wines N, Kossard S., Procollagen 1 expression in atypical fibroxanthoma and other tumors. J Cutan Pathol 2004; 31: 57.
35. de Feraudy S, Mar N, McCalmont TH., Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. Am J Surg Pathol. 2008; 32: 1111.
36. Facchetti F, Bertalot G, Grigolato PG., KP1 (CD68) staining of malignant melanomas. Histopathology 1991; 19: 141.
37. Tsang WW, Chan JC., KP1(CD68) staining of granular cell neoplasms: is KP1 a marker for lysosomes rather than the histiocytic lineage? Histopathology 1992; 21: 84.
38. Pulford KA, Rigney EM, Micklem KJ., et al., KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989; 42: 414.
39. McCalmont TH., Brother (and sister), can you spare the S100? J Cutan Pathol. 2010; 37: 299.